Company intelligence / Profile preview

Lumendi

Ownership: Private
Development stage: Commercial

Overview

Lumendi has developed and commercialized the DiLumen platform, a suite of FDA-cleared, single-use disposable endotherapy devices that enhance navigation, stability, and control during complex lower GI procedures. Over 4,000 procedures have been performed with their devices in the US, EU, UK, and Asia since launch. Clinical results indicate improved outcomes for complex polyp resections with reduced procedure times and complications compared to traditional surgery.

Therapeutic areas: Gastroenterology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

MICRO‑TECH Endoscopy – distribution partnership for United Kingdom & Ireland.Collaborations with leading endoscopists & GI surgeons on Clinical Advisory Board.

Beyond the preview

Go deeper on Lumendi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lumendi.

Explore the full profile